It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2014.
2014 | Nagpur, Maharashtra, India | ActiveMedineutrina Private Limited, a active private limited company, was established on 06 August 2014 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U51900MH2014PTC256947. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shila Manendra Kshirsagar (Director), Dilipkumar Gulabchand Bora (Director). Past directors included Mahendra Dashrathrao Kshirsagar, Shila Manendra Kshirsagar, Dilipkumar Gulabchand Bora. It holds ₹7.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 20, Near Kdk College, Shree Nagar, Nandanwan,, Nagpur, Maharashtra, 440009.
U51900MH2014PTC256947
256947
06 August 2014
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medineutrina Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shila Manendra Kshirsagar | Director | 28 Apr 2021 | Current |
| Dilipkumar Gulabchand Bora | Director | 01 Oct 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 29 Apr 2021 | Past |
| Pramod Abcsdd | Director | 31 Dec 2015 | Past |
| Pramod Abcsdd | Director | 31 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medineutrina Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1642.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Medineutrina had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2017 | Others | ₹2.00 M | Open |
| 29 Mar 2017 | Others | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medineutrina, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medineutrina, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medineutrina's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medineutrina Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Medineutrina Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Shila Manendra Kshirsagar was appointed as a Director was appointed as a Director on 28 Apr 2021 & has been associated with this company since 4 years 7 months . was completed.
The activity A charge with Others amounted to Rs. 2.00 M with Charge ID 100094480 was registered on 29 Mar 2017. was completed.
The activity A charge with Others amounted to Rs. 5.00 M with Charge ID 100094477 was registered on 29 Mar 2017. was completed.
Progress on Dilipkumar Gulabchand Bora was appointed as a Director was appointed as a Director on 01 Oct 2015 & has been associated with this company since 10 years 2 months . was documented.
The CIN of Medineutrina Private Limited is U51900MH2014PTC256947.
Medineutrina Private Limited is headquartered at Plot No. 20, Near Kdk College, Shree Nagar, Nandanwan,, Nagpur, Maharashtra, 440009.
Medineutrina Private Limited was incorporated on 06 August 2014.
The current directors of Medineutrina Private Limited are
The primary industry of Medineutrina Private Limited is Pharma.
Medineutrina Private Limited is unlisted.
The authorized capital of Medineutrina Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medineutrina Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX